You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

MYLAN PHARMS INC Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?

MYLAN PHARMS INC has eighty-seven approved drugs.

There are nineteen tentative approvals on MYLAN PHARMS INC drugs.

Summary for MYLAN PHARMS INC

US Patents:	0
Tradenames:	76
Ingredients:	75
NDAs:	87

Drugs and US Patents for MYLAN PHARMS INC

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Pharms Inc	DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE	doxylamine succinate; pyridoxine hydrochloride	TABLET, DELAYED RELEASE;ORAL	207825-001	Jul 6, 2020	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	076577-001	Sep 10, 2003	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	ESZOPICLONE	eszopiclone	TABLET;ORAL	091151-001	Mar 26, 2013	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	076801-001	Aug 17, 2012		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	ARMODAFINIL	armodafinil	TABLET;ORAL	200043-003	Jun 1, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	RILUZOLE	riluzole	TABLET;ORAL	203042-001	Jul 1, 2013	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Mylan Pharms Inc	IBANDRONATE SODIUM	ibandronate sodium	TABLET;ORAL	078995-001	Mar 19, 2012		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MYLAN PHARMS INC

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	4,971,800	⤷ Try a Trial
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	5,045,317	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.